NASDAQ:GRAL Grail (GRAL) Stock Price, News & Analysis $14.92 -0.06 (-0.40%) (As of 08/27/2024 ET) Add Compare Share Share Today's Range$14.81▼$15.2350-Day Range N/A52-Week Range$12.51▼$23.36Volume617,778 shsAverage Volume1.48 million shsMarket Capitalization$463.31 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestTrends Get Grail alerts: Email Address Ad Investors AlleyLabor day: 59% dividend from Bitcoin (No Crypto Needed)I've got something exciting for you this Labor Day... How about a 59.07% dividend from Bitcoin? And it pays out almost EVERY MONTH.This report is available FREE with our Labor Day special: About Grail Stock (NASDAQ:GRAL)GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.Read More GRAL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GRAL Stock News HeadlinesAugust 27 at 8:44 AM | msn.comCrazy_Grail_Air_Jordan_Travis_Scott_sneaker_in_a_10000_Mystery_Box_shorts_sneakers_trendingAugust 27 at 3:44 AM | msn.comHoly grail of gigglesAugust 28, 2024 | Paradigm Press (Ad)Forget the Polls, Here’s What Will Happen this ElectionAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… August 26 at 8:21 AM | yahoo.comThis 'Holy Grail' Protein Repairs DNA And Could Lead to a Cancer VaccineAugust 25 at 4:49 AM | msn.comHawaii-style taro donuts with Holey Grail DonutsAugust 23, 2024 | finance.yahoo.comGolden Grail Beverages Announces New Business StrategyAugust 23, 2024 | forbes.comOne Grail To Rule Them All - Reference 2524 In PlatinumAugust 23, 2024 | msn.comWhy Chekhov’s Arkadina is the holy grail for all great actressesAugust 28, 2024 | Paradigm Press (Ad)Forget the Polls, Here’s What Will Happen this ElectionAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… August 21, 2024 | prnewswire.comGRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceAugust 21, 2024 | finance.yahoo.comGolden Grail Beverages Appoints Scott Lomo as Interim Chief Executive OfficerAugust 21, 2024 | seekingalpha.comIllumina Sees The Light: GRAIL Is Gone, Focus Restored (Rating Upgrade)August 19, 2024 | msn.comA Holy Grail Collection of Derelict Million-Dollar Classics Is Going to AuctionAugust 19, 2024 | msn.comNew Artifacts Recovered From 'Holy Grail' of Spanish Shipwrecks That Sank With Fortune in ColombiaAugust 18, 2024 | msn.comShoppers say 'holy grail' oil-serum hybrid is the key to 'radiant, dewy' skinAugust 17, 2024 | msn.comThe Only Major Actors Still Alive From Monty Python And The Holy GrailAugust 16, 2024 | msn.comChemist shares 'holy grail' for combating skin imperfections - and it's less than £4August 16, 2024 | finance.yahoo.comGrail to shed 350 workers in restructuringSee More Headlines Receive GRAL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Grail and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today8/27/2024Next Earnings (Estimated)11/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostics & Research Sub-IndustryHealthcare Current SymbolNASDAQ:GRAL Previous SymbolNASDAQ:GRAL CUSIPN/A CIK1699031 WebN/A Phone(650) 771-9796FaxN/AEmployees1,360Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$109.74 million Price / Sales4.22 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares31,053,000Free FloatN/AMarket Cap$463.31 million OptionableOptionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Robert P. Ragusa (Age 64)CEO & Director Comp: $1.48MDr. Joshua J. Ofman M.D. (Age 59)M.S.H.S, President Comp: $1.04MMr. Aaron FreidinChief Financial OfficerMr. Paul CiccolellaSenior VP of Global Development & OperationsMs. Amoolya Singh Ph.D.Senior VP of Research & Chief Scientific OfficerMr. Abram Barth J.D.M.P.H., General CounselMs. Julie CurrieChief People OfficerMr. Rodger CurrieVP and Head of Government Affairs & Alliance DevelopmentSir Harpal S. Kumar M.A.M.B.A., MA, MBA, MEng, President Biopharma Business & EuropeDr. Satnam Alag Ph.D.Senior VP of Software Engineering & Chief Security OfficerMore ExecutivesKey CompetitorsBrightSpring Health ServicesNASDAQ:BTSGNational HealthCareNYSE:NHCFortreaNASDAQ:FTREagilon healthNYSE:AGLCareDxNASDAQ:CDNAView All Competitors GRAL Stock Analysis - Frequently Asked Questions How have GRAL shares performed this year? Grail's stock was trading at $14.57 on January 1st, 2024. Since then, GRAL shares have increased by 2.4% and is now trading at $14.92. View the best growth stocks for 2024 here. How do I buy shares of Grail? Shares of GRAL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:GRAL) was last updated on 8/28/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredIs This the End of the Dow? (See Proof)Major Financial System Upgrade to Hit Like a Shockwave A radical new upgrade to our entire financial system...Banyan Hill Publishing | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredWhat is Nvidia’s New $1 Trillion SuperProject?Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThis Crypto Is Set to Explode in AugustThe Bitcoin Halving ignited the 2024 boom, and altcoins are primed to SKYROCKET. Last year we tipped off ou...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grail, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grail With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.